Factor Xa inhibitors: all 607 studies that test it
Page 1 of 7. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- To Evaluate The Efficacy And Safety Of Rivaroxaban In Combination With Aspirin Compared With Aspirin Monotherapy In Patients With Stable Coronary Artery Disease (CAD) and High Ischemic RiskNot yet recruitingNCT07928583Not applicable
- Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple MyelomaRecruitingNCT07907211Phase 4
- Vortosiran in Atrial FibrillationNot yet recruitingNCT07870889Phase 2
- Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee ArthroplastyRecruitingNCT07869615Not applicable
- Edoxaban Versus Apixaban in Cancer-Associated Venous ThromboembolismNot yet recruitingNCT07852637Phase 4
- Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening IschemiaRecruitingNCT07832578Early Phase 1
- Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis OutcomesRecruitingNCT07820670Not applicable
- Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban TherapyRecruitingNCT07796217Phase 4
- Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)Not yet recruitingNCT07779746Phase 3
- Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery DiseaseRecruitingNCT07753200Phase 4
- Apixaban to Prevent Decompensation of Early Liver Cirrhosis TrialNot yet recruitingNCT07726693Phase 3
- Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism ProphylaxisNot yet recruitingNCT07716332Not applicable
- Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic DiseaseNot yet recruitingNCT07713875Phase 4
- Apixaban Versus Warfarin for Left Ventricular ThrombusRecruitingNCT07709780Phase 3
- Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseRecruitingNCT07613840Not applicable
- Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic StrokeNot yet recruitingNCT07609654Phase 4
- Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein ThrombosisNot yet recruitingNCT07602062Not applicable
- Effect of Apiban Therapy on AVF Maturation in ESRD PatientsRecruitingNCT07559942Not applicable
- Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisRecruitingNCT07521332Phase 4
- Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery EctasiaRecruitingNCT07511257Phase 4
- SWITCH: Apixaban vs Vitamin K in HM3RecruitingNCT07471139Phase 3
- Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)Not yet recruitingNCT07468448Phase 3
- Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LSRecruitingNCT07461545Not applicable
- Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSDRecruitingNCT07461532Not applicable
- Rivaroxaban vs Warfarin in Patients With Mechanical Heart ValvesEnrolling by invitationNCT07456085Phase 3
- Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ TrialRecruitingNCT07454707Phase 3
- Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVRNot yet recruitingNCT07434661Phase 3
- Rivaroxaban in Idiopathic Membranous NephropathyRecruitingNCT07404436Phase 4
- Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)Not yet recruitingNCT07404345Phase 4
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesRecruitingNCT07270263Not applicable
- Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT PreventionRecruitingNCT07243080Phase 4
- BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral AtherosclerosisRecruitingNCT07237308Phase 4
- Hip Fracture Surgery Arterial and Venous Thrombotic Events PreventionNot yet recruitingNCT07228663Phase 3
- Rivaroxaban for Slow Coronary Flow After PCI in STEMINot yet recruitingNCT07195812Phase 4
- Apixaban or Enoxaparin After Head and Neck Cancer SurgeryRecruitingNCT07189897Phase 4
- Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer TreatmentRecruitingNCT07160686Phase 3
- Edoxaban Steady-State PK/PD in Adults With Nephrotic SyndromeNot yet recruitingNCT07116239Not applicable
- DOAC - Dosing Options in AntiCoagulation ProphylaxisRecruitingNCT07005024Phase 3
- Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseRecruitingNCT06978439Phase 4
- Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk ReductionRecruitingNCT06961630Early Phase 1
- Comparing the Safety and Efficacy of Apixaban and RivaroxabanRecruitingNCT06953726Phase 4
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral AnticoagulantRecruitingNCT06901466Phase 4
- Low Dose Edoxaban in Elderly Patients With AF and a History of StrokeNot yet recruitingNCT06900725Phase 2/3
- Apixaban in ThrombocytopeniaRecruitingNCT06886516Early Phase 1
- VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb RevascularizationRecruitingNCT06873321Phase 4
- Excretion of Rivaroxaban in Human Breast MilkRecruitingNCT06831474Phase 1
- Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac CatheterizationRecruitingNCT06812455Phase 4
- Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's SyndromeRecruitingNCT06780462Phase 3
- Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial InfarctionRecruitingNCT06742567Phase 3
- A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular CoagulationNot yet recruitingNCT06729034Phase 2
- Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric SurgeryRecruitingNCT06689241Not applicable
- ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip ArthroplastyRecruitingNCT06611319Phase 3
- Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple MyelomaNot yet recruitingNCT06580223Phase 3
- Dabigatran Versus Rivaroxaban in Cerebral Venous ThrombosisRecruitingNCT06551402Phase 3
- Rivaroxaban Versus Apixaban in Cerebral Venous ThrombosisRecruitingNCT06531122Phase 3
- Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) TrialRecruitingNCT06523959Phase 4
- Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial InfarctionRecruitingNCT06515730Phase 4
- Stroke Prevention In Ischemic Stroke With Covert Atrial FibrillationRecruitingNCT06486792Phase 4
- Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic ValvesNot yet recruitingNCT06476301Phase 4
- Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple MyelomaRecruitingNCT06474182Not applicable
- Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic StrokeNot yet recruitingNCT06396858Phase 4
- Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai VolunteersNot yet recruitingNCT06388239Phase 1
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingNCT06370273Phase 3
- Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial HaemorrhageRecruitingNCT06322953Phase 3
- EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllationRecruitingNCT06285942Not applicable
- Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter AblationRecruitingNCT06216769Not applicable
- Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma PatientsRecruitingNCT06196918Not applicable
- RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTingRecruitingNCT06195540Phase 3
- Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial FibrillationRecruitingNCT06187311Phase 4
- Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer PatientsNot yet recruitingNCT06149533Phase 3
- Recanalization Rate of Acute DVTNot yet recruitingNCT06145269Early Phase 1
- Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial FibrillationRecruitingNCT06108414Phase 4
- Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary InterventionNot yet recruitingNCT06103266Phase 4
- Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and PolymorphismsRecruitingNCT06065592Phase 1
- Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical TrialRecruitingNCT05973188Phase 4
- Low-dose NOAC Versus GDMT After LAAORecruitingNCT05960721Not applicable
- VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic TherapyRecruitingNCT05920343Phase 2/3
- Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial InfarctionRecruitingNCT05892042Not applicable
- DOAC in Patients with Child a or B Liver CirrhosisRecruitingNCT05869591Phase 2
- Anticoagulation in Post MI LV Thrombus Trial in NepalRecruitingNCT05794399Phase 4
- HIP Fracture Oral thromboPROphylaxis (Hip PRO Pilot)RecruitingNCT05775965Phase 2
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
- Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.Not yet recruitingNCT05718531Phase 3
- Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic StenosisNot yet recruitingNCT05700266Phase 2/3
- DIrect Oral Anticoagulation and Bioprothesis Aortic ValveNot yet recruitingNCT05687448Phase 3
- Venous Thromboembolism Prevention in Outpatients With GliomaRecruitingNCT05683808Phase 2
- Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseRecruitingNCT05643651Phase 4
- NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCIRecruitingNCT05638867Phase 4
- Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral StenosisRecruitingNCT05540587Phase 2
- Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism RiskNot yet recruitingNCT05487950Phase 4
- Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord InjuryRecruitingNCT05484557Not applicable
- Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease PatientsRecruitingNCT05410275Phase 3
- PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 YearsRecruitingNCT05387954Phase 3
- Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyRecruitingNCT05180773Phase 4
- Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome PatientsRecruitingNCT05116995Phase 4
- Primary Thromboprophylaxis in Patients With Malignancy and Central Venous CathetersRecruitingNCT05029063Phase 3
- The API-CALF Study: Apixaban to Treat Calf Vein ThrombosisNot yet recruitingNCT04981327Phase 3
- Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver CirrhosisRecruitingNCT04874428Phase 1
- Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein StentingRecruitingNCT04694248Not applicable
- BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.RecruitingNCT04666454Phase 4